Genetics of primary macronodular adrenal hyperplasia
- Maria Candida Barisson Villares Fragoso1,2⇑,
- Guilherme Asmar Alencar1,
- Antonio Marcondes Lerario2,
- Isabelle Bourdeau3,
- Madson Queiroz Almeida1,2,
- Berenice Bilharinho Mendonca1 and
- André Lacroix3
- 1Unidade de Suprarrenal, Disciplina de Endocrinologia e Metabologia, Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo, São
Paulo, Brazil
2Instituto do Câncer de São Paulo ICESP, São Paulo, Brazil
3Département de Médecine, Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada
- Correspondence should be addressed to M C B V Fragoso; Email: maria.villares{at}hc.fm.usp.br
Abstract
ACTH-independent macronodular adrenal hyperplasia is a rare cause of Cushing's syndrome (CS), accounting for <2% of all endogenous CS cases; however it is more frequently identified incidentally with sub-clinical cortisol secretion. Recently, cortisol secretion has been shown to be regulated by ectopic corticotropin, which is in turn produced by clusters of steroidogenic cells of the hyperplastic adrenal nodules. Hence, the term ‘ACTH-independent’ is not entirely appropriate for this disorder. Accordingly, the disease is designated primary macronodular adrenal hyperplasia (PMAH) in this review article. The means by which cortisol production is regulated in PMAH despite the suppressed levels of ACTH of pituitary origin is exceedingly complex. Several molecular events have been proposed to explain the enhanced cortisol secretion, increased cell proliferation, and nodule formation in PMAH. Nonetheless, the precise sequence of events and the molecular mechanisms underlying this condition remain unclear. The purpose of this review is therefore to present new insights on the molecular and genetic profile of PMAH pathophysiology, and to discuss the implications for disease progression.
- Received in final form 27 October 2014
- Accepted 29 October 2014
- © 2015 Society for Endocrinology